These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32687239)

  • 21. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
    Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
    Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study.
    Takkunen MJ; Schwab US; de Mello VD; Eriksson JG; Lindström J; Tuomilehto J; Uusitupa MI;
    Eur J Nutr; 2016 Apr; 55(3):967-79. PubMed ID: 25930966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
    van Bommel EJM; Herrema H; Davids M; Kramer MHH; Nieuwdorp M; van Raalte DH
    Diabetes Metab; 2020 Apr; 46(2):164-168. PubMed ID: 31816432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort.
    Semnani-Azad Z; Johnston LW; Lee C; Retnakaran R; Connelly PW; Harris SB; Zinman B; Hanley AJ
    BMJ Open Diabetes Res Care; 2019; 7(1):e000825. PubMed ID: 31803485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes.
    Liu H; Zhang H; Wang X; Yu X; Hu C; Zhang X
    Surg Obes Relat Dis; 2018 May; 14(5):584-593. PubMed ID: 29459013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
    Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
    PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
    Kempf T; Guba-Quint A; Torgerson J; Magnone MC; Haefliger C; Bobadilla M; Wollert KC
    Eur J Endocrinol; 2012 Nov; 167(5):671-8. PubMed ID: 22918303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal Helminth Infection Improves Insulin Sensitivity, Decreases Systemic Inflammation, and Alters the Composition of Gut Microbiota in Distinct Mouse Models of Type 2 Diabetes.
    Khudhair Z; Alhallaf R; Eichenberger RM; Whan J; Kupz A; Field M; Krause L; Wilson DT; Daly NL; Giacomin P; Sotillo J; Loukas A
    Front Endocrinol (Lausanne); 2020; 11():606530. PubMed ID: 33613446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial.
    Roager HM; Vogt JK; Kristensen M; Hansen LBS; Ibrügger S; Mærkedahl RB; Bahl MI; Lind MV; Nielsen RL; Frøkiær H; Gøbel RJ; Landberg R; Ross AB; Brix S; Holck J; Meyer AS; Sparholt MH; Christensen AF; Carvalho V; Hartmann B; Holst JJ; Rumessen JJ; Linneberg A; Sicheritz-Pontén T; Dalgaard MD; Blennow A; Frandsen HL; Villas-Bôas S; Kristiansen K; Vestergaard H; Hansen T; Ekstrøm CT; Ritz C; Nielsen HB; Pedersen OB; Gupta R; Lauritzen L; Licht TR
    Gut; 2019 Jan; 68(1):83-93. PubMed ID: 29097438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary Alaska pollock protein alters insulin sensitivity and gut microbiota composition in rats.
    Hosomi R; Nishimoto A; Kobayashi T; Ikeda Y; Mitsui M; Shimono T; Kanda S; Nishiyama T; Yoshida M; Fukunaga K
    J Food Sci; 2020 Oct; 85(10):3628-3637. PubMed ID: 32885439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.
    Tabák AG; Jokela M; Akbaraly TN; Brunner EJ; Kivimäki M; Witte DR
    Lancet; 2009 Jun; 373(9682):2215-21. PubMed ID: 19515410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mechanistic Model of Gut-Brain Axis Perturbation and High-Fat Diet Pathways to Gut Microbiome Homeostatic Disruption, Systemic Inflammation, and Type 2 Diabetes.
    Lew KN; Starkweather A; Cong X; Judge M
    Biol Res Nurs; 2019 Jul; 21(4):384-399. PubMed ID: 31113222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
    Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
    Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
    Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals.
    Benedict C; Vogel H; Jonas W; Woting A; Blaut M; Schürmann A; Cedernaes J
    Mol Metab; 2016 Dec; 5(12):1175-1186. PubMed ID: 27900260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies.
    Jiang Z; Sun TY; He Y; Gou W; Zuo LS; Fu Y; Miao Z; Shuai M; Xu F; Xiao C; Liang Y; Wang J; Xu Y; Jing LP; Ling W; Zhou H; Chen YM; Zheng JS
    BMC Med; 2020 Dec; 18(1):371. PubMed ID: 33267887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.
    Lorenzo C; Williams K; Haffner SM
    Diabet Med; 2012 Aug; 29(8):e151-8. PubMed ID: 22435928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.